Combination therapy with nivolumab and tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma.

被引：0
|
作者：
Garmezy, Benjamin
Zhang, Tian
Laccetti, Andrew Leonard
Economides, Minas P.
Shah, Amishi Yogesh
Tannir, Nizar M.
Jonasch, Eric
Msaouel, Pavlos
Zurita, Amado J.
Corn, Paul Gettys
Venkatesan, Aradhana M.
Brown, Landon Carter
Kao, Chester
Kinsey, Emily Noelle
Harrison, Michael Roger
Armstrong, Andrew J.
George, Daniel J.
Campbell, Matthew T.
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Duke Canc Inst, Durham, NC USA
[3] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e17090
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Are tyrosine kinase inhibitors fit for purpose in the treatment of metastatic papillary renal cell carcinoma?
    Hemmant, Joshua
    Chow, Karyee
    JOURNAL OF CLINICAL UROLOGY, 2021, 14 (03) : 175 - 178
  • [32] Spine Stereotactic Radiosurgery with Concurrent Tyrosine Kinase Inhibitors for Metastatic Renal Cell Carcinoma
    Miller, Jacob A.
    Balagamwala, Ehsan
    Angelov, Lilyana
    Suh, John
    Rini, Brian
    Garcia, Jorge
    Ahluwalia, Manmeet
    Chao, Samuel
    JOURNAL OF NEUROSURGERY, 2016, 124 (04) : A1195 - A1195
  • [33] Impact of Tyrosine Kinase Inhibitors on the Incidence of Brain Metastasis in Metastatic Renal Cell Carcinoma
    Verma, Jonathan
    Jonasch, Eric
    Allen, Pamela
    Tannir, Nizar
    Mahajan, Anita
    CANCER, 2011, 117 (21) : 4958 - 4965
  • [34] Long-Term Response to Tyrosine Kinase Inhibitors for Metastatic Renal Cell Carcinoma
    Catalano, Martina
    De Giorgi, Ugo
    Maruzzo, Marco
    Bimbatti, Davide
    Buti, Sebastiano
    Mazzaschi, Giulia
    Procopio, Giuseppe
    Santoni, Matteo
    Galli, Luca
    Conca, Raffaele
    Doni, Laura
    Antonuzzo, Lorenzo
    Roviello, Giandomenico
    BIOMEDICINES, 2022, 10 (10)
  • [35] Spine stereotactic radiosurgery with concurrent tyrosine kinase inhibitors for metastatic renal cell carcinoma
    Miller, Jacob A.
    Balagamwala, Ehsan H.
    Angelov, Lilyana
    Suh, John H.
    Rini, Brian
    Garcia, Jorge A.
    Ahluwalia, Manmeet
    Chao, Samuel T.
    JOURNAL OF NEUROSURGERY-SPINE, 2016, 25 (06) : 766 - 774
  • [36] Nivolumab in Combination with Stereotactic Body Radiotherapy in Pretreated Patients with Metastatic Renal Cell Carcinoma. Results of the Phase II NIVES Study
    Grabbert, Markus
    Grosu, Anca L.
    Zamboglou, Constantinos
    Gratzke, Christian
    EUROPEAN UROLOGY, 2022, 81 (06) : 622 - 622
  • [37] Nivolumab in Combination with Stereotactic Body Radiotherapy in Pretreated Patients with Metastatic Renal Cell Carcinoma. Results of the Phase II NIVES Study
    Masini, Cristina
    Iotti, Cinzia
    De Giorgi, Ugo
    Bellia, Roberto Salvatore
    Buti, Sebastiano
    Salaroli, Francesco
    Zampiva, Ilaria
    Mazzarotto, Renzo
    Mucciarini, Claudia
    Vitale, Maria Giuseppa
    Bruni, Alessio
    Lohr, Frank
    Procopio, Giuseppe
    Caffo, Orazio
    Nole, Franco
    Morelli, Franco
    Baier, Susanne
    Buttigliero, Consuelo
    Ciammella, Patrizia
    Timon, Giorgia
    Fantinel, Emanuela
    Carlinfante, Gabriele
    Berselli, Annalisa
    Pinto, Carmine
    EUROPEAN UROLOGY, 2022, 81 (03) : 274 - 282
  • [38] Efficacy of axitinib in patients with metastatic renal cell carcinoma refractory to nivolumab therapy
    Yoshida, Kazuhiko
    Takagi, Toshio
    Kondo, Tsunenori
    Kobayashi, Hirohito
    Iizuka, Junpei
    Fukuda, Hironori
    Ishihara, Hiroki
    Okumi, Masayoshi
    Ishida, Hideki
    Tanabe, Kazunari
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2019, 49 (06) : 576 - 580
  • [39] Novel tyrosine kinase inhibitors for renal cell carcinoma
    Dorff, Tanya B.
    Pal, Sumanta K.
    Quinn, David I.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2014, 7 (01) : 67 - 73
  • [40] Combination cabozantinib and nivolumab treatment in patients with refractory metastatic renal cell carcinoma (mRCC)
    Kinsey, Emily
    Brown, Landon
    Kao, Chester
    Healy, Patrick
    Harrison, Michael
    McNamara, Megan
    Armstrong, Andrew
    Ramalingham, Sundhar
    George, Daniel
    Zhang, Tian
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
12345